Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Inhibikase Therapeutics, Inc. Common Stock

IKT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of IKT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
IKT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
IKT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
IKT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in IKT holdings by institutional investors

Quarterly net insider trading by IKT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for IKT

Quiver Logo

No former government officials on record as having lobbied for IKT

Revolving Door Dashboard

IKT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

IKT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
IKT Income Statement
IKT Balance Sheet
IKT Cash Flow
U.S. Patents

New IKT patent grants

  • Patent Title: Compositions and methods for inhibiting kinases May. 19, 2026
  • Patent Title: Compositions and methods for inhibiting kinases Aug. 15, 2023
  • Patent Title: Compositions and methods for inhibiting kinases Aug. 09, 2022
  • Patent Title: Compositions and methods for inhibiting kinases Feb. 02, 2021
  • Patent Title: Compositions and methods for inhibiting kinases Jul. 09, 2019
  • Patent Title: Compositions and methods for inhibiting kinases Jun. 11, 2019
  • Patent Title: Compositions and methods for inhibiting kinases Nov. 06, 2018
  • Patent Title: Methods of treating tumoral diseases, or bacterial or viral infections Mar. 06, 2018
  • Patent Title: Compositions and methods for inhibiting kinases Nov. 28, 2017
  • Patent Title: Compounds and compositions thereof Nov. 08, 2016
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to IKT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
IKT News

Recent insights relating to IKT

CNBC Recommendations

Recent picks made for IKT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IKT

IKT Analyst Ratings

IKT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
IKT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $IKT stock a Buy, Sell, or Hold?

  • What is the price target for $IKT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

IKT Top Shareholders
Shareholder
Shares Held
IKT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $IKT stock?

  • Who owns the most shares of $IKT stock?

  • What funds own $IKT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

IKT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view IKT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About IKT

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

  • Address Wilmington, DE
  • Market Cap 287.4 million
  • Employees 35
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Inhibikase Therapeutics, Inc. Common Stock (IKT) Historical Stock Prices

Inhibikase Therapeutics, Inc. Common Stock (IKT) closed at $2.06 on September 25, 2026. Over the past year its adjusted close ranged from $1.41 to $2.52. Daily prices go back to December 23, 2020, 1,445 trading days in all.

  • 1 month-17.27%
  • 3 months+7.85%
  • Year to date+0.49%
  • 1 year+32.90%
  • 3 years+49.28%
  • 5 years-83.09%
  • Max-96.53%
See every congressional and insider trade on the IKT price chart

Quiver Premium charts IKT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 2.10 2.15 2.04 2.06 2.06 447,301
Sep 24, 2026 2.15 2.17 2.08 2.10 2.10 499,103
Sep 23, 2026 2.30 2.31 2.14 2.15 2.15 412,347
Sep 22, 2026 2.23 2.33 2.21 2.31 2.31 468,654
Sep 21, 2026 2.31 2.32 2.19 2.20 2.20 366,096
Sep 18, 2026 2.31 2.35 2.28 2.30 2.30 3,209,727
Sep 17, 2026 2.31 2.37 2.29 2.30 2.30 475,530
Sep 16, 2026 2.32 2.35 2.26 2.31 2.31 370,502
Sep 15, 2026 2.40 2.40 2.25 2.31 2.31 480,903
Sep 14, 2026 2.34 2.42 2.34 2.39 2.39 482,938
Sep 11, 2026 2.37 2.39 2.32 2.34 2.34 303,242
Sep 10, 2026 2.37 2.38 2.32 2.33 2.33 332,368
Sep 9, 2026 2.43 2.45 2.38 2.41 2.41 323,426
Sep 8, 2026 2.45 2.52 2.43 2.43 2.43 310,497
Sep 4, 2026 2.49 2.55 2.48 2.50 2.50 246,962
Sep 3, 2026 2.50 2.61 2.46 2.52 2.52 564,219
Sep 2, 2026 2.39 2.54 2.39 2.50 2.50 379,048
Sep 1, 2026 2.30 2.40 2.27 2.38 2.38 523,236
Aug 31, 2026 2.41 2.44 2.30 2.31 2.31 329,872
Aug 28, 2026 2.48 2.48 2.37 2.41 2.41 307,959
Aug 27, 2026 2.48 2.50 2.40 2.47 2.47 202,087
Aug 26, 2026 2.50 2.51 2.43 2.49 2.49 244,699
Aug 25, 2026 2.53 2.54 2.46 2.50 2.50 453,435
Aug 24, 2026 2.41 2.54 2.35 2.50 2.50 735,926
Aug 21, 2026 2.38 2.42 2.37 2.39 2.39 309,319
Aug 20, 2026 2.45 2.47 2.33 2.35 2.35 539,987
Aug 19, 2026 2.44 2.52 2.43 2.45 2.45 644,989
Aug 18, 2026 2.36 2.41 2.31 2.40 2.40 343,969
Aug 17, 2026 2.41 2.42 2.32 2.39 2.39 489,780
Aug 14, 2026 2.39 2.44 2.37 2.41 2.41 227,885
Aug 13, 2026 2.43 2.46 2.33 2.41 2.41 360,729
Aug 12, 2026 2.38 2.47 2.38 2.40 2.40 296,947
Aug 11, 2026 2.48 2.52 2.41 2.45 2.45 580,835
Aug 10, 2026 2.44 2.52 2.42 2.46 2.46 479,216
Aug 7, 2026 2.38 2.48 2.38 2.47 2.47 386,846
Aug 6, 2026 2.39 2.49 2.38 2.41 2.41 422,921
Aug 5, 2026 2.46 2.50 2.33 2.40 2.40 1,108,540
Aug 4, 2026 2.25 2.46 2.24 2.44 2.44 1,255,022
Aug 3, 2026 2.19 2.29 2.15 2.21 2.21 486,556
Jul 31, 2026 2.27 2.29 2.13 2.18 2.18 369,550
Jul 30, 2026 2.21 2.32 2.19 2.28 2.28 403,660
Jul 29, 2026 2.31 2.33 2.17 2.21 2.21 685,382
Jul 28, 2026 2.35 2.39 2.27 2.31 2.31 472,198
Jul 27, 2026 2.36 2.39 2.31 2.35 2.35 513,872
Jul 24, 2026 2.37 2.53 2.32 2.33 2.33 2,158,411
Jul 23, 2026 2.13 2.34 2.12 2.33 2.33 1,347,743
Jul 22, 2026 2.20 2.25 2.15 2.17 2.17 632,092
Jul 21, 2026 2.23 2.32 2.18 2.23 2.23 901,335
Jul 20, 2026 2.11 2.26 2.10 2.23 2.23 1,072,648
Jul 17, 2026 1.96 2.15 1.94 2.11 2.11 1,735,684
Jul 16, 2026 2.06 2.08 1.95 2.01 2.01 584,115
Jul 15, 2026 2.08 2.10 1.99 2.06 2.06 981,720
Jul 14, 2026 2.06 2.36 1.93 2.06 2.06 4,077,439
Jul 13, 2026 2.03 2.05 1.95 1.96 1.96 356,735
Jul 10, 2026 2.03 2.04 1.94 2.04 2.04 584,745
Jul 9, 2026 2.07 2.09 1.94 2.04 2.04 621,013
Jul 8, 2026 2.04 2.10 1.98 2.07 2.07 1,079,844
Jul 7, 2026 1.98 2.12 1.97 2.05 2.05 1,265,321
Jul 6, 2026 2.00 2.03 1.94 1.98 1.98 413,663
Jul 2, 2026 1.97 2.04 1.95 1.99 1.99 678,998
Jul 1, 2026 2.02 2.10 1.91 1.94 1.94 918,882
Jun 30, 2026 1.93 2.05 1.92 2.03 2.03 1,523,921
Jun 29, 2026 1.89 1.93 1.84 1.93 1.93 514,111
Jun 26, 2026 1.83 1.93 1.83 1.91 1.91 3,820,394
Jun 25, 2026 1.86 1.92 1.85 1.87 1.87 571,351
Jun 24, 2026 1.87 1.92 1.85 1.87 1.87 937,766
Jun 23, 2026 1.82 1.89 1.80 1.87 1.87 546,296
Jun 22, 2026 1.83 1.88 1.78 1.84 1.84 602,425
Jun 18, 2026 1.72 1.83 1.71 1.83 1.83 1,484,537
Jun 17, 2026 1.68 1.73 1.66 1.68 1.68 677,003
Jun 16, 2026 1.67 1.70 1.64 1.67 1.67 694,516
Jun 15, 2026 1.67 1.73 1.65 1.67 1.67 375,349
Jun 12, 2026 1.68 1.72 1.67 1.67 1.67 424,715
Jun 11, 2026 1.69 1.70 1.65 1.67 1.67 338,512
Jun 10, 2026 1.71 1.72 1.65 1.66 1.66 645,438
Jun 9, 2026 1.65 1.69 1.60 1.67 1.67 792,922
Jun 8, 2026 1.67 1.68 1.61 1.62 1.62 605,709
Jun 5, 2026 1.68 1.69 1.61 1.63 1.63 627,330
Jun 4, 2026 1.70 1.73 1.65 1.66 1.66 437,259
Jun 3, 2026 1.70 1.74 1.65 1.67 1.67 845,831
Jun 2, 2026 1.70 1.73 1.66 1.70 1.70 526,411
Jun 1, 2026 1.75 1.79 1.70 1.71 1.71 517,736
May 29, 2026 1.75 1.77 1.73 1.75 1.75 306,268
May 28, 2026 1.70 1.78 1.69 1.77 1.77 423,776
May 27, 2026 1.71 1.74 1.70 1.70 1.70 537,459
May 26, 2026 1.73 1.75 1.69 1.70 1.70 413,780
May 22, 2026 1.73 1.79 1.69 1.69 1.69 512,162
May 21, 2026 1.65 1.77 1.63 1.74 1.74 977,141
May 20, 2026 1.58 1.70 1.57 1.68 1.68 674,897
May 19, 2026 1.58 1.60 1.53 1.57 1.57 1,367,241
May 18, 2026 1.73 1.77 1.57 1.61 1.61 1,717,030
May 15, 2026 1.84 1.84 1.72 1.73 1.73 947,904
May 14, 2026 1.91 1.93 1.83 1.86 1.86 287,391
May 13, 2026 1.89 1.95 1.87 1.90 1.90 792,461
May 12, 2026 2.01 2.04 1.91 1.92 1.92 592,495
May 11, 2026 2.07 2.13 2.02 2.03 2.03 506,885
May 8, 2026 1.98 2.10 1.95 2.06 2.06 955,805
May 7, 2026 2.01 2.04 1.91 1.99 1.99 796,488
May 6, 2026 1.94 2.01 1.90 2.01 2.01 668,942
May 5, 2026 1.97 1.99 1.91 1.93 1.93 446,510
May 4, 2026 1.91 1.99 1.89 1.94 1.94 451,944
May 1, 2026 1.87 1.91 1.83 1.91 1.91 945,966
Apr 30, 2026 1.86 1.94 1.86 1.89 1.89 433,681
Apr 29, 2026 1.86 1.89 1.83 1.86 1.86 553,522
Apr 28, 2026 1.88 1.90 1.84 1.88 1.88 544,064
Apr 27, 2026 1.86 1.92 1.85 1.89 1.89 690,463
Apr 24, 2026 1.92 1.95 1.86 1.88 1.88 630,650
Apr 23, 2026 1.82 1.95 1.78 1.93 1.93 1,027,263
Apr 22, 2026 1.70 1.82 1.66 1.82 1.82 956,999
Apr 21, 2026 1.79 1.80 1.63 1.67 1.67 2,591,937
Apr 20, 2026 1.84 1.92 1.76 1.81 1.81 1,831,987
Apr 17, 2026 1.73 1.85 1.72 1.83 1.83 1,620,479
Apr 16, 2026 1.79 1.79 1.67 1.70 1.70 841,198
Apr 15, 2026 1.69 1.80 1.69 1.79 1.79 1,096,987
Apr 14, 2026 1.70 1.75 1.69 1.70 1.70 1,377,211
Apr 13, 2026 1.71 1.77 1.68 1.71 1.71 816,734
Apr 10, 2026 1.69 1.74 1.67 1.70 1.70 864,320
Apr 9, 2026 1.73 1.76 1.67 1.69 1.69 1,114,465
Apr 8, 2026 1.83 1.83 1.72 1.74 1.74 701,694
Apr 7, 2026 1.79 1.80 1.69 1.76 1.76 732,491
Apr 6, 2026 1.78 1.83 1.75 1.79 1.79 692,790
Apr 2, 2026 1.74 1.83 1.73 1.80 1.80 759,859
Apr 1, 2026 1.71 1.83 1.70 1.81 1.81 1,165,034
Mar 31, 2026 1.62 1.69 1.59 1.68 1.68 648,560
Mar 30, 2026 1.69 1.69 1.57 1.58 1.58 897,306
Mar 27, 2026 1.65 1.76 1.62 1.68 1.68 762,911
Mar 26, 2026 1.61 1.69 1.61 1.63 1.63 551,616
Mar 25, 2026 1.60 1.70 1.60 1.63 1.63 1,129,619
Mar 24, 2026 1.72 1.73 1.57 1.60 1.60 6,307,159
Mar 23, 2026 1.82 1.86 1.70 1.74 1.74 1,091,711
Mar 20, 2026 1.84 1.88 1.77 1.80 1.80 8,868,806
Mar 19, 2026 1.80 1.90 1.78 1.83 1.83 1,058,946
Mar 18, 2026 1.93 2.03 1.83 1.83 1.83 1,082,321
Mar 17, 2026 1.98 2.06 1.95 1.96 1.96 1,133,541
Mar 16, 2026 2.02 2.06 1.96 1.98 1.98 1,237,614
Mar 13, 2026 1.93 2.02 1.86 2.00 2.00 1,170,561
Mar 12, 2026 1.95 2.00 1.90 1.99 1.99 910,689
Mar 11, 2026 1.95 2.03 1.93 2.02 2.02 765,651
Mar 10, 2026 1.86 2.00 1.86 1.95 1.95 1,886,188
Mar 9, 2026 1.88 1.90 1.80 1.89 1.89 1,295,906
Mar 6, 2026 1.84 1.97 1.83 1.88 1.88 1,077,229
Mar 5, 2026 1.95 1.97 1.80 1.89 1.89 2,359,285
Mar 4, 2026 1.98 2.08 1.94 1.95 1.95 1,770,785
Mar 3, 2026 1.91 1.97 1.85 1.91 1.91 1,158,097
Mar 2, 2026 1.95 1.99 1.92 1.93 1.93 1,205,152
Feb 27, 2026 2.07 2.10 2.02 2.05 2.05 1,260,917
Feb 26, 2026 2.14 2.14 1.95 2.09 2.09 2,468,661
Feb 25, 2026 2.05 2.26 2.03 2.14 2.14 2,880,788
Feb 24, 2026 1.83 2.06 1.80 2.05 2.05 4,019,334
Feb 23, 2026 1.98 2.11 1.75 1.80 1.80 41,817,886
Feb 20, 2026 1.74 1.77 1.70 1.76 1.76 673,731
Feb 19, 2026 1.79 1.80 1.74 1.74 1.74 472,871
Feb 18, 2026 1.71 1.83 1.69 1.80 1.80 1,003,701
Feb 17, 2026 1.67 1.72 1.65 1.69 1.69 542,504
Feb 13, 2026 1.64 1.73 1.64 1.67 1.67 225,762
Feb 12, 2026 1.69 1.70 1.61 1.64 1.64 429,811
Feb 11, 2026 1.62 1.72 1.57 1.71 1.71 619,993
Feb 10, 2026 1.65 1.66 1.60 1.60 1.60 684,531
Feb 9, 2026 1.72 1.72 1.62 1.65 1.65 494,072
Feb 6, 2026 1.59 1.74 1.59 1.70 1.70 1,511,714
Feb 5, 2026 1.54 1.59 1.53 1.58 1.58 865,154
Feb 4, 2026 1.60 1.61 1.53 1.56 1.56 2,543,102
Feb 3, 2026 1.58 1.60 1.54 1.58 1.58 596,076
Feb 2, 2026 1.49 1.60 1.49 1.57 1.57 553,293
Jan 30, 2026 1.55 1.60 1.50 1.50 1.50 661,545
Jan 29, 2026 1.59 1.60 1.55 1.57 1.57 327,543
Jan 28, 2026 1.72 1.72 1.59 1.59 1.59 581,500
Jan 27, 2026 1.65 1.71 1.63 1.69 1.69 707,848
Jan 26, 2026 1.73 1.76 1.64 1.65 1.65 525,256
Jan 23, 2026 1.81 1.85 1.73 1.74 1.74 346,795
Jan 22, 2026 1.79 1.88 1.75 1.80 1.80 459,118
Jan 21, 2026 1.82 1.85 1.70 1.75 1.75 885,855
Jan 20, 2026 1.65 1.68 1.61 1.65 1.65 311,473
Jan 16, 2026 1.66 1.72 1.63 1.67 1.67 319,026
Jan 15, 2026 1.70 1.70 1.64 1.65 1.65 303,717
Jan 14, 2026 1.68 1.72 1.67 1.70 1.70 186,335
Jan 13, 2026 1.68 1.73 1.64 1.68 1.68 220,431
Jan 12, 2026 1.71 1.71 1.63 1.71 1.71 672,309
Jan 9, 2026 1.67 1.76 1.65 1.72 1.72 629,731
Jan 8, 2026 1.90 1.90 1.66 1.67 1.67 667,130
Jan 7, 2026 2.00 2.02 1.80 1.89 1.89 570,501
Jan 6, 2026 2.01 2.10 1.94 2.00 2.00 867,416
Jan 5, 2026 1.97 2.16 1.96 2.01 2.01 842,451
Jan 2, 2026 2.07 2.09 1.94 1.95 1.95 298,402
Dec 31, 2025 1.98 2.06 1.94 2.05 2.05 506,400
Dec 30, 2025 1.94 2.04 1.91 1.97 1.97 361,724
Dec 29, 2025 1.99 2.15 1.89 1.96 1.96 777,547
Dec 26, 2025 1.79 2.05 1.71 2.00 2.00 2,082,562
Dec 24, 2025 1.59 1.69 1.58 1.65 1.65 714,975
Dec 23, 2025 1.65 1.67 1.56 1.59 1.59 462,795
Dec 22, 2025 1.71 1.79 1.62 1.66 1.66 1,288,010
Dec 19, 2025 1.67 1.75 1.60 1.72 1.72 742,129
Dec 18, 2025 1.62 1.73 1.56 1.67 1.67 436,941
Dec 17, 2025 1.59 1.64 1.55 1.59 1.59 609,250
Dec 16, 2025 1.61 1.67 1.51 1.60 1.60 932,644
Dec 15, 2025 1.56 1.65 1.52 1.62 1.62 932,673
Dec 12, 2025 1.55 1.56 1.50 1.54 1.54 642,185
Dec 11, 2025 1.52 1.57 1.48 1.52 1.52 490,322
Dec 10, 2025 1.45 1.51 1.44 1.48 1.48 224,063
Dec 9, 2025 1.44 1.55 1.44 1.46 1.46 242,842
Dec 8, 2025 1.51 1.55 1.43 1.44 1.44 253,799
Dec 5, 2025 1.54 1.57 1.49 1.50 1.50 101,320
Dec 4, 2025 1.45 1.56 1.45 1.51 1.51 667,103
Dec 3, 2025 1.42 1.48 1.40 1.44 1.44 160,424
Dec 2, 2025 1.52 1.55 1.41 1.41 1.41 376,132
Dec 1, 2025 1.51 1.55 1.50 1.50 1.50 292,187
Nov 28, 2025 1.56 1.60 1.52 1.52 1.52 253,995
Nov 26, 2025 1.55 1.60 1.52 1.54 1.54 286,401
Nov 25, 2025 1.59 1.61 1.48 1.57 1.57 353,547
Nov 24, 2025 1.49 1.61 1.48 1.55 1.55 733,563
Nov 21, 2025 1.57 1.66 1.48 1.49 1.49 3,182,018
Nov 20, 2025 1.60 1.63 1.51 1.53 1.53 230,161
Nov 19, 2025 1.58 1.65 1.53 1.56 1.56 41,535
Nov 18, 2025 1.51 1.62 1.50 1.60 1.60 26,251
Nov 17, 2025 1.51 1.62 1.51 1.52 1.52 71,559
Nov 14, 2025 1.57 1.63 1.52 1.53 1.53 76,766
Nov 13, 2025 1.59 1.62 1.57 1.60 1.60 39,024
Nov 12, 2025 1.64 1.67 1.55 1.62 1.62 114,950
Nov 11, 2025 1.59 1.66 1.59 1.64 1.64 34,992
Nov 10, 2025 1.51 1.67 1.51 1.59 1.59 146,898
Nov 7, 2025 1.47 1.51 1.39 1.50 1.50 76,879
Nov 6, 2025 1.69 1.69 1.49 1.49 1.49 117,517
Nov 5, 2025 1.60 1.72 1.58 1.70 1.70 210,883
Nov 4, 2025 1.62 1.70 1.54 1.59 1.59 200,972
Nov 3, 2025 1.46 1.76 1.33 1.60 1.60 320,922
Oct 31, 2025 1.46 1.49 1.43 1.47 1.47 46,880
Oct 30, 2025 1.45 1.49 1.44 1.46 1.46 62,588
Oct 29, 2025 1.47 1.52 1.43 1.43 1.43 119,228
Oct 28, 2025 1.55 1.57 1.46 1.47 1.47 91,742
Oct 27, 2025 1.56 1.59 1.50 1.56 1.56 42,568
Oct 24, 2025 1.55 1.56 1.49 1.54 1.54 75,105
Oct 23, 2025 1.54 1.55 1.50 1.53 1.53 20,281
Oct 22, 2025 1.58 1.60 1.49 1.54 1.54 106,525
Oct 21, 2025 1.62 1.62 1.55 1.58 1.58 49,876
Oct 20, 2025 1.62 1.65 1.56 1.62 1.62 92,503
Oct 17, 2025 1.50 1.65 1.47 1.57 1.57 217,278
Oct 16, 2025 1.66 1.66 1.47 1.51 1.51 236,082
Oct 15, 2025 1.60 1.67 1.55 1.60 1.60 136,674
Oct 14, 2025 1.58 1.62 1.53 1.62 1.62 73,108
Oct 13, 2025 1.65 1.67 1.58 1.63 1.63 61,257
Oct 10, 2025 1.66 1.68 1.58 1.61 1.61 93,502
Oct 9, 2025 1.65 1.68 1.60 1.66 1.66 102,208
Oct 8, 2025 1.65 1.75 1.60 1.66 1.66 180,889
Oct 7, 2025 1.60 1.65 1.57 1.62 1.62 51,702
Oct 6, 2025 1.62 1.67 1.58 1.62 1.62 91,994
Oct 3, 2025 1.65 1.70 1.57 1.66 1.66 75,327
Oct 2, 2025 1.61 1.67 1.58 1.64 1.64 68,184
Oct 1, 2025 1.61 1.66 1.57 1.61 1.61 41,581
Sep 30, 2025 1.51 1.62 1.50 1.62 1.62 122,750
Sep 29, 2025 1.54 1.56 1.50 1.53 1.53 65,193
Sep 26, 2025 1.54 1.59 1.50 1.55 1.55 88,634
Sep 25, 2025 1.70 1.72 1.53 1.55 1.55 79,831

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Inhibikase Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at IKT, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation